2020年5月4日，中山大学附属孙逸仙纪念医院&广东省人民医院在Molecular Cancer (中科院一区 IF=27.7)期刊上在线发表题为 "circNFIB1 inhibits lymphangiogenesis and lymphatic ...

Renal cell carcinoma (RCC) is the third most common cancer of the urinary system. There is a pressing need for specific biomarkers for advanced/metastatic RCC to enhance diagnostic accuracy and ...

Adding the VEGF inhibitor ramucirumab (Cyramza) to the EGFR inhibitor osimertinib (Tagrisso) slowed progression of untreated ...

As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

The regulation and remodeling of the tumor microenvironment (TME) are closely associated with how cancers typically progress ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

Mum Michelle Freeman, 51, has been given the devastating news that she has just 13 months left to live after being diagnosed ...

Anti-VEGF consists of medicated eye injections that target the underlying causes of wet AMD. This treatment is also sometimes recommended for other retinal conditions, such as macular edema caused ...

TU2218 is a novel oral dual inhibitor targeting TGFR1 and VEGFR2. TGF-ß and VEGF pathways are known to suppress the activity of immune checkpoint inhibitors (ICIs), so TU2218 is expected to improve ...

Michelle Freeman first faced tragedy when her youngest child was diagnosed with cancer at just two, now she's in an almost 10 ...